Assistant Professor, Family Medicine and Community Health, Case Western Reserve University School of Medicine
Family Medicine
Dr. Sheng Liu, MD
|
|
Give Review
Sheng Liu, MD practices Family Medicine. He received awards:"Physician Practice Connections Recognition Program" and "Patient-Centered Medical Home Recognition Program". Dr. Sheng Liu has written publications. He has 27 publications published with PubMed. The lastest publication is: 'SSBP1 Suppresses TGF-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling.
- Tetraphenylethene modified [n]rotaxanes: synthesis, characterization and aggregation-induced emission behavior.
- Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis.
- Chemical control of photochromism and a multiresponsive molecular switch based on a diarylethene derivative containing naphthol.
- Identification of the man-made barium copper silicate pigments among some ancient Chinese artifacts through spectroscopic analysis.
- Imides modified benzopicenes: synthesis, solid structure and optoelectronic properties.
- Photo-responsive [2]catenanes: synthesis and properties.
- Dithienylethene-based rotaxanes: synthesis, characterization and properties.
- P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer.
- Dynamic expression of chymotrypsin-like elastase 1 over the course of murine lung development.
- Construction of rotacatenanes using rotaxane and catenane frameworks.
- 2-Deoxy-d-glucose attenuates sevoflurane-induced neuroinflammation through nuclear factor-kappa B pathway in vitro.
- Open label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC vs. the combination of paclitaxel and everolimus followed by ...
- (1)H, (13)C and (15)N resonance assignment of the N-terminal domain of human lysyl aminoacyl tRNA synthetase.
- Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer.
- Upregulation of miR-370 contributes to the progression of gastric carcinoma via suppression of FOXO1.
- MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation.
- Endothelial cell phagocytosis of senescent neutrophils decreases procoagulant activity.
- Functional proteomics characterization of residual breast cancer after neoadjuvant systemic chemotherapy.
- Integrin ?v?6 as a novel marker for diagnosis and metastatic potential of thyroid carcinoma.
- Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes.
- Colorimetric detection of DNA damage by using hemin-graphene nanocomposites.
- Human skin neural crest progenitor cells are susceptible to BRAF(V600E)-induced transformation.
- Kinetic quantification of protein polymer nanoparticles using non-invasive imaging.
- Histone deacetylase inhibitors suppress mutant p53 transcription via histone deacetylase 8.
- JNK suppresses pulmonary fibroblast elastogenesis during alveolar development.
Schools
Capital Institute Of Medical Sciences
Metro Health Med Center
Doctors Specialties
- Family Medicine
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Tiered Hosp/Ind Direct Access OH
- Anthem Blue Cross Blue Shield HMO
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- CareSource
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Golden Rule
- Choice Care PPO
- Medicaid
- Medical Mutual of Ohio POS
- Medicare MCR
- Mutual of Omaha
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Physician Practice Connections Recognition Program
- Patient-Centered Medical Home Recognition Program
Education
-
Case Western Reserve University - MetroHealth -
Capital University of Medical Sciences
Hospital
-
MetroHealth Medical Center
Drug Facts
| NPI NUMBER | 1073615712 | |
| NPPES Provider LastName | LIU | |
| NPPES Provider FirstName | SHENG | |
| NPPES Provider ZIPCode | 441091900 | |
| NPPES Provider State | OH | |
| Specialty Description | Family Practice | |
| Total Claim Count | 7556.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 307.0 | |
| Percent Opioid Claims | 4.06 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1073615712 |
| Last Name Of The Provider | LIU |
| First Name Of The Provider | SHENG |
| View All |
Similar Doctors
|
|
Dr. Catherine E. Watkins-Campbell, MD |
|
|
Dr. S Suresh S. Reddy, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pavani Adusumilli, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Scott H. Frank, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew J. Goldman, MD |
|
|
Dr. Sheryar Sarwar, MD |
|
|
Dr. Robert B. Kelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sasha E. Yurgionas, MD |
|
|
Dr. Mahdi M. Awwad, MD |
|
|
Dr. Sarah A. Sweeney, MD |
|
|
Amir Boutros |